Renal Cancer - Results from #2880

On the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment-Cytokines, Targeted Therapy, and Immunotherapy. April 9, 2020

Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinoma. April 9, 2020

Analysis of the nuclear expression of pSer727-STAT3 as a prognostic factor in patients with clear cell renal carcinoma. April 8, 2020

Localized solitary left renal vein thrombus complicating nutcracker syndrome: a case report and review of the literature. April 8, 2020

Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel. April 8, 2020

From Wilms to kidney tumors: which ones require a biopsy? April 7, 2020

Prognostic Implication of Body Mass Index on Survival Outcomes in Surgically Treated Nonmetastatic Renal Cell Carcinoma: A Single-Institutional Retrospective Analysis of a Large Cohort. April 7, 2020

Quantifying the impact of surgical decompression on quality of life and identification of factors associated with outcomes in patients with symptomatic metastatic spinal cord compression. April 6, 2020

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia. March 27, 2020

Sex-specific analysis of renal cell carcinoma histology and survival in Japan: A population-based study 2004 to 2016. March 27, 2020

Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets. March 26, 2020

Differential expression analysis of clear cell renal cell carcinomas in THE CANCER GENOME ATLAS distinguishes an aggressive subset enriched with chromosome 7 and 12 gains. March 26, 2020

Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer. March 26, 2020

Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study. March 26, 2020

Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney. March 25, 2020

The Association between Chronic Conditions, End-of-Life Health Care Use, and Documentation of Advance Care Planning among Patients with Cancer. March 25, 2020

Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease. March 25, 2020

Oncological and functional outcomes of open versus laparoscopic partial nephrectomy in T1b tumors: A single-center analysis. March 25, 2020

Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma. March 24, 2020

A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma. March 24, 2020

Page 145 of 456